指南与共识消化内镜胰腺与胆道疾病

内镜下乳头切除术专家共识:德尔菲法

Expert consensus on endoscopic papillectomy using a Delphi process.
指南 / 共识 · Gastrointest Endosc · 2021-04-19

共识涉及诊断应含十二指肠镜和活检、特定情况转外科、术前直肠NSAIDs和胰管支架预防胰腺炎、随访间隔等。

要点

  • 诊断评估应包括十二指肠镜(100%共识)和活检取样(94%共识)。
  • 疑似乳头恶性肿瘤或导管内延伸超过1 cm者应转外科切除(76%共识)。
  • 预防胰腺炎:术前直肠NSAIDs(82%共识)和放置胰管支架(100%共识)。

核心结论

  • 这是制定内镜下乳头腺瘤管理国际共识算法的第一步,但在许多领域未能达成共识,应成为未来研究重点。

主要发现

  • 诊断评估应包括十二指肠镜(100%共识)和活检取样(94%共识),选择性使用额外腹部影像(75%-81%共识)。
  • 疑似乳头恶性肿瘤或导管内延伸超过1 cm应转外科切除(76%共识)。
  • 预防胰腺炎:术前直肠NSAIDs(82%共识)和放置胰管支架(100%共识)。
  • 胆道支架适用于乳头区域持续出血(76%共识)或切除后怀疑(微)穿孔(88%共识);随访应在初始乳头切除术后3至6个月开始,每6至12个月重复,至少5年(75%共识)。

关键数值与推荐

  • 共识阈值:≥70%同意。
  • 诊断评估:十二指肠镜100%共识,活检94%共识,额外腹部影像75%-81%共识。
  • 转外科指征:疑似乳头恶性肿瘤或导管内延伸超过1 cm,76%共识。
  • 预防胰腺炎:术前直肠NSAIDs 82%共识,胰管支架100%共识。
  • 胆道支架指征:持续出血76%共识,怀疑(微)穿孔88%共识;随访间隔3至6个月开始,每6至12个月,至少5年,75%共识。

临床怎么用

  • 临床可参考共识推荐进行诊断评估、预防胰腺炎、放置胆道支架及制定随访计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Consensus regarding an optimal algorithm for endoscopic treatment of papillary adenomas has not been established. We aimed to assess the existing degree of consensus among international experts and develop further concordance by means of a Delphi process. METHODS: Fifty-two international experts in the field of endoscopic papillectomy were invited to participate. Data were collected between August and December 2019 using an online survey platform. Three rounds were conducted. Consensus was defined as ≥70% agreement. RESULTS: Sixteen experts (31%) completed the full process, and consensus was achieved on 47 of the final 79 statements (59%). Diagnostic workup should include at least an upper endoscopy using a duodenoscope (100%) and biopsy sampling (94%). There should be selected use of additional abdominal imaging (75%-81%). Patients with (suspected) papillary malignancy or over 1 cm intraductal extension should be referred for surgical resection (76%). To prevent pancreatitis, rectal nonsteroidal anti-inflammatory drugs should be administered before resection (82%) and a pancreatic stent should be placed (100%). A biliary stent is indicated in case of ongoing bleeding from the papillary region (76%) or concerns for a (micro)perforation after resection (88%). Follow-up should be started 3 to 6 months after initial papillectomy and repeated every 6 to 12 months for at least 5 years (75%). CONCLUSIONS: This is the first step in developing an international consensus-based algorithm for endoscopic management of papillary adenomas. Surprisingly, in many areas consensus could not be achieved. These aspects should be the focus of future studies.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Fritzsche JA, Fockens P, Barthet M, et al. Expert consensus on endoscopic papillectomy using a Delphi process. Gastrointest Endosc. 2021. PMID: 33887269. doi:10.1016/j.gie.2021.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。